Literature DB >> 12470565

Hysteroscopic treatment of Asherman's syndrome.

Adam Magos1.   

Abstract

Although Asherman's syndrome (the presence of adhesions inside the cervical canal or uterine cavity) is relatively uncommon in the general population, it can be the cause of menstrual irregularity and subfertility in high risk women. The diagnosis is usually confirmed by hysterosalpinography, and more recently by hysteroscopy. Hysteroscopy has also become accepted as the optimum route of surgery, the aims being to restore the size and shape of the uterine cavity, normal endometrial function and fertility. Treatment can range from simple cervical dilatation in the case of cervical stenosis but an intact uterine cavity, to extensive adhesiolysis of dense intrauterine adhesions using scissors or electro- or laser energy. Patients in whom the uterine fundus is completely obscured, and those with a greatly narrowed, fibrotic cavity present the greatest therapeutic challenge. Several techniques have described for these difficult cases, but outcome is far worse than in patients with mild, endometrial-type adhesions. Non-hysteroscopic techniques area also beginning to be developed, but whether they will replace the current 'gold' standard of hysteroscopy remains to be seen.

Entities:  

Mesh:

Year:  2002        PMID: 12470565     DOI: 10.1016/s1472-6483(12)60116-3

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  8 in total

Review 1.  Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.

Authors:  Nasser Chegini
Journal:  Semin Reprod Med       Date:  2010-04-22       Impact factor: 1.303

2.  AAGL practice report: practice guidelines on intrauterine adhesions developed in collaboration with the European Society of Gynaecological Endoscopy (ESGE).

Authors: 
Journal:  Gynecol Surg       Date:  2017-05-01

3.  Extracorporeal Shock Wave Therapy Combined with Platelet-Rich Plasma during Preventive and Therapeutic Stages of Intrauterine Adhesion in a Rat Model.

Authors:  Yin-Hua Cheng; Ni-Chin Tsai; Yun-Ju Chen; Pei-Ling Weng; Yun-Chiao Chang; Jai-Hong Cheng; Jih-Yang Ko; Hong-Yo Kang; Kuo-Chung Lan
Journal:  Biomedicines       Date:  2022-02-17

4.  Comparison of the localization of intrauterine adhesions in pregnant and infertile women.

Authors:  Rukiye Ada Bender; Canan Özcan; Bertan Akar; Eray Çalışkan
Journal:  Turk J Obstet Gynecol       Date:  2022-09-23

5.  The role of preoperative 3D-ultrasound in intraoperative judgement for hysteroscopic adhesiolysis.

Authors:  Arvind Burjoo; Xingping Zhao; Lingxiao Zou; Xinyi Liu; Lei Lei; Baiyun Zhang; Dabao Xu
Journal:  Ann Transl Med       Date:  2020-02

Review 6.  Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction.

Authors:  Andrea Ciavattini; Jacopo Di Giuseppe; Piergiorgio Stortoni; Nina Montik; Stefano R Giannubilo; Pietro Litta; Md Soriful Islam; Andrea L Tranquilli; Fernando M Reis; Pasquapina Ciarmela
Journal:  Obstet Gynecol Int       Date:  2013-09-12

Review 7.  The management of Asherman syndrome: a review of literature.

Authors:  Alessandro Conforti; Carlo Alviggi; Antonio Mollo; Giuseppe De Placido; Adam Magos
Journal:  Reprod Biol Endocrinol       Date:  2013-12-27       Impact factor: 5.211

8.  Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial.

Authors:  Yun Cao; Haixiang Sun; Hui Zhu; Xianghong Zhu; Xiaoqiu Tang; Guijun Yan; Jingmei Wang; Donghui Bai; Juan Wang; Liu Wang; Qi Zhou; Huiyan Wang; Chengyan Dai; Lijun Ding; Biyun Xu; Yan Zhou; Jie Hao; Jianwu Dai; Yali Hu
Journal:  Stem Cell Res Ther       Date:  2018-07-11       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.